Results 51 to 60 of about 89 (85)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

ISEV2026 Abstract Book

Journal of Extracellular Vesicles, Volume 15, Issue S1, June 2026.
wiley   +1 more source

ePoster

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

ePosters Virtual

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

The rollercoaster of vaccine-induced immune thrombotic thrombocytopenia

The Lancet Haematology, 2022
openaire   +2 more sources

Vaccine-induced immune thrombotic thrombocytopenia (VITT)

Seminars in Hematology, 2022
openaire   +2 more sources

The first known case of vaccine‐induced thrombotic thrombocytopenia in Australia [PDF]

Medical Journal of Australia, 2021
Jay Hocking, Sanjeev D Chunilal, Vivien M Chen, Tim Brighton, James Nguyen, Jocelyn Tan, Stephen B Ting, Huyen Tran   +7 more
openaire   +2 more sources

COVID-19 vaccine-induced thrombotic thrombocytopenia

Canadian Family Physician, 2022
Kevin Pottie, Alan Ng Cheng Hin, Ammar Saad   +2 more
openaire   +1 more source

COVID-19 vaccine-induced immune thrombotic thrombocytopenia: Correspondence

Annals of Thoracic Medicine
Sookaromdee, Pathum, Wiwanitkit, Viroj
openaire   +2 more sources

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)

Seminars in Hematology, 2022
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a novel prothrombotic disorder characterized by thrombosis, thrombocytopenia, and disseminated intravascular coagulation identified in hundreds of recipients of ChAdOx1 nCoV-19 (Oxford/AstraZeneca), an adenovirus vector coronavirus disease 2019 (COVID-19) vaccine.
Ishac Nazy, Theodore E. Warkentin, Donald M Arnold   +2 more
exaly   +3 more sources